Are Men's Testosterone Levels Declining? What the Research Reveals About Hormones, Fertility, and Longevity
Are Men's Testosterone Levels Declining? What the Research Reveals About Hormones, Fertility, and Longevity
AI Overview: Research suggests that testosterone concentrations have declined across generations of men, beyond changes associated with normal aging. Claims of a 56% testosterone decline since 1973 appear to confuse testosterone research with studies of declining sperm counts. Potential contributors include obesity, visceral adiposity, metabolic dysfunction, endocrine-disrupting chemicals, and changes in overall health. The causes remain incompletely understood, and lower testosterone does not automatically establish a need for hormone replacement.
One-Minute Read
Several population studies have documented declining testosterone concentrations in men, including changes not fully explained by aging, obesity, or other measured health characteristics. Separate research found that average sperm concentration declined by approximately 52% between 1973 and 2018.
Excess adiposity, particularly visceral fat, is strongly associated with lower circulating testosterone. A 2026 analysis found that measures of body fat were considerably more informative than age alone in explaining differences in testosterone among American men. Environmental chemicals, reproductive development, sleep, and chronic illness may also contribute, although their relative effects on population trends remain uncertain.
From a preventive longevity medicine perspective, testosterone should be evaluated within the broader context of metabolic health, cardiovascular risk, body composition, symptoms, and reproductive goals.
Are Testosterone Levels Really Falling?
Claims that men's testosterone levels have fallen by more than 50% since the 1970s circulate frequently on social media. The underlying concern is legitimate, although the statistic generally comes from research on sperm counts rather than measurements of testosterone.
A major systematic review published in Human Reproduction Update examined studies involving men from multiple continents, with semen samples collected between 1973 and 2018. The researchers estimated a 51.6% decline in average sperm concentration and a 62.3% decline in total sperm count among men not selected according to fertility status. These findings raised important questions about changes in male reproductive health, although sperm production and circulating testosterone represent different aspects of reproductive physiology.
Evidence of declining testosterone comes from separate investigations. In 2007, researchers examining the Massachusetts Male Aging Study reported a substantial population-level reduction in serum testosterone that persisted after accounting for age and measured changes in lifestyle and health. The investigators estimated an age-independent decline of approximately 1.3% annually within the population and observation period studied.
Subsequent research involving younger men has also identified lower testosterone concentrations in more recent survey periods. Differences in laboratory methods, sampling, population characteristics, and study design complicate comparisons across decades. Nevertheless, the findings suggest that chronological aging alone cannot explain every observed change in male hormone health.
Visceral Fat and Metabolic Health
Among the factors associated with lower testosterone, excess adiposity has some of the strongest clinical evidence. Testosterone and metabolic health have a reciprocal relationship involving insulin sensitivity, inflammation, adipose tissue signaling, and the hypothalamic-pituitary-gonadal axis.
Obesity is frequently accompanied by lower circulating sex hormone-binding globulin (SHBG), which can reduce measured total testosterone without necessarily producing an equivalent reduction in free testosterone. More advanced metabolic dysfunction may also interfere with the hormonal signaling responsible for testosterone production.
Research published in August 2026 in the Journal of the Endocrine Society examined 4,984 American men ages 20 to 59 using National Health and Nutrition Examination Survey data. Chronological age alone explained approximately 2.5% of the statistical variation in circulating testosterone. Measures of adiposity, including total body fat, visceral fat, and waist circumference, explained approximately 18% to 20%.
The study was cross-sectional and cannot establish whether excess body fat caused lower testosterone or determine the contribution of adiposity to historical testosterone trends. It does, however, reinforce the importance of evaluating body composition and metabolic health when investigating low testosterone.
This relationship also helps explain why weight reduction, improved insulin sensitivity, exercise, and adequate nutrition can improve testosterone concentrations in some men, particularly those with obesity-related functional suppression. The response varies, and men with primary testicular disease or other established causes of hypogonadism may not experience the same improvement.
Environmental Chemicals and Male Reproductive Development
The possibility that environmental exposures contribute to changes in male reproductive health has attracted increasing scientific interest. Many chemicals encountered in food packaging, plastics, agricultural products, cosmetics, and industrial environments can interact with endocrine signaling systems.
Phthalates, bisphenols, certain pesticides, and persistent environmental pollutants have demonstrated endocrine-disrupting activity in experimental research. Depending on the compound and exposure conditions, these substances may influence androgen synthesis, hormone receptors, oxidative stress, or the development and function of reproductive tissues.
Exposure timing may be particularly important. The male reproductive system begins developing before birth, and hormonal signaling during fetal development influences the formation and later function of the testes. Puberty represents another period of endocrine sensitivity. Potential effects therefore extend beyond exposures occurring during adulthood.
Human observational research has identified associations between certain environmental chemicals and measures of testosterone, semen quality, or reproductive development, although findings are not consistent across every chemical or population. People are also exposed to complex mixtures rather than individual compounds in isolation, making it difficult to assign causation or estimate the contribution of environmental exposures to generational changes.
The biological plausibility warrants continued investigation, particularly because some exposure sources are widespread and involve critical periods of development. Current evidence does not support attributing the population-level decline in testosterone to one chemical or class of chemicals.
Sleep, Physical Activity, and Other Influences
Testosterone production is influenced by interactions among sleep, circadian rhythms, nutritional status, energy availability, and overall health. Sleep disturbances and chronic medical conditions may contribute to reduced testosterone, although individual responses vary.
Obstructive sleep apnea is particularly relevant in men with obesity and metabolic dysfunction. These conditions commonly coexist, and changes in testosterone may reflect several overlapping physiological influences. Treating sleep apnea offers important cardiovascular and functional benefits, but it does not consistently normalize testosterone concentrations.
Physical activity supports insulin sensitivity, muscle maintenance, and body composition. Resistance training is especially valuable for preserving strength and physical function during aging, although exercise should not be presented as a reliable method for substantially increasing resting testosterone in otherwise healthy men.
Medications, including chronic opioids and systemic glucocorticoids, can suppress reproductive hormone signaling. Testicular disorders, pituitary disease, significant illness, and inadequate energy intake also deserve consideration in men with symptoms or repeatedly low hormone measurements.
Testosterone, Fertility, and the Limits of Hormone Replacement
Testosterone is involved in sexual development, libido, erythropoiesis, bone metabolism, and the maintenance of muscle and other tissues. Within the testes, very high local testosterone concentrations are necessary for normal sperm production. Circulating testosterone measurements, however, do not provide a complete assessment of fertility.
Men can have normal serum testosterone despite abnormal sperm parameters, and fertility may be preserved in some men with reduced circulating testosterone. Semen analysis and reproductive hormone testing address different clinical questions.
This distinction becomes particularly important when considering testosterone replacement therapy. Exogenous testosterone suppresses pituitary luteinizing hormone and follicle-stimulating hormone signaling, potentially reducing intratesticular testosterone concentrations and substantially impairing sperm production. Men who wish to preserve fertility require an approach that accounts for their reproductive goals before treatment begins.
Testosterone therapy may be appropriate for men with confirmed hypogonadism and relevant symptoms after evaluation of potential causes, benefits, contraindications, and treatment risks. It should not be viewed as a general response to population-level testosterone trends or an intervention proven to extend lifespan in men with normal testosterone.
Looking Beyond a Testosterone Number
At HormoneSynergy®, hormone health is considered within the broader physiology of aging rather than evaluated through a single laboratory value. Testosterone concentrations are interpreted alongside symptoms, medications, body composition, metabolic function, cardiovascular health, sleep, and relevant medical history.
When testosterone deficiency is suspected, evaluation generally begins with appropriately timed morning measurements, repeated when indicated. Free testosterone and SHBG may help clarify results in men whose total testosterone is affected by obesity or altered binding proteins. Gonadotropins and other testing can help distinguish testicular dysfunction from changes involving pituitary or hypothalamic signaling.
Body composition provides additional clinical information. Visceral adiposity, skeletal muscle mass, and regional fat distribution are not adequately described by body weight or BMI alone. Assessments such as DEXA body composition and bioimpedance analysis may help characterize these relationships and follow changes over time.
Cardiovascular and metabolic health also deserve attention because low testosterone frequently coexists with insulin resistance, obesity, type 2 diabetes, and cardiovascular disease. An association does not establish that testosterone deficiency is the principal cause of these conditions or that testosterone treatment will reverse them.
Preserving muscle, limiting excess visceral fat, improving metabolic health, and addressing sleep and cardiovascular risk remain important clinical objectives whether or not testosterone replacement is indicated.
What the Generational Decline May Be Telling Us
The research on testosterone and sperm counts suggests that male reproductive health may be influenced by changes extending beyond the ordinary biological effects of aging. Increasing adiposity and metabolic disease provide part of the explanation, while environmental exposures, developmental influences, and other population-level changes remain active areas of investigation.
The relationship between hormones and healthy aging is complex. Testosterone can be both a participant in physiological function and a marker of underlying health. Lower concentrations sometimes reflect a treatable endocrine disorder, but they may also accompany changes in metabolic health, medications, sleep, or systemic illness.
Understanding these relationships requires more than identifying a numerical decline. The clinical goal is to determine what is contributing to an individual's hormonal status, whether treatment is indicated, and how reproductive, metabolic, cardiovascular, and musculoskeletal health can be supported over time.
Related HormoneSynergy® Resources
- Bioidentical Hormones and Testosterone Therapy
- Body Composition and Longevity Medicine
- Preventive Cardiology and Longevity Medicine
- Optimal Aging Assessment
- Longevity Medicine Resource Library
Selected Research
- Travison TG, et al. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92(1):196–202. PubMed.
- Levine H, et al. Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries. Hum Reprod Update. 2023;29(2):157–176. PubMed.
- Potter AW, Friedl KE. Adiposity, not chronological aging, is the dominant determinant of circulating testosterone in US adult men. J Endocr Soc. 2026;10(9):bvag194. PubMed.
- Endocrine Society. Testosterone Therapy for Hypogonadism Clinical Practice Guideline. Clinical guideline.
HormoneSynergy® | Evidence-Based Preventive Longevity Medicine
Portland – Lake Oswego, Oregon
This article is provided for general educational purposes and is not a substitute for individualized medical evaluation.
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →